Advertisement

PharmacoEconomics & Outcomes News

, Volume 820, Issue 1, pp 24–24 | Cite as

Nivolumab not cost efficient for NSCLC in Spain

Clinical study
  • 3 Downloads

Reference

  1. Merino Almazan M, et al. A multicentre observational study of the effectiveness, safety and economic impact of nivolumab on non-small-cell lung cancer in real clinical practice. International Journal of Clinical Pharmacy : 22 Dec 2018. Available from: URL: http://doi.org/10.1007/s11096-018-0772-z

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations